Stockreport

Novartis Announces Positive Results From Late-Stage Study on Fabhalta [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Fabhalta is an oral, Factor B inhibitor of the alternative complement pathway. APPULSE-PNH is a phase IIIB multicenter, single-arm, open-label study to evaluate the e [Read more]